Lipodystrophy Syndromes.
Hussain I, Garg A.
Endocrinol Metab Clin North Am. 2016 Dec;45(4):783-797. doi: 10.1016/j.ecl.2016.06.012. Epub 2016 Oct 6.
The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
Brown RJ, Araujo-Vilar D, Cheung PT, Dunger D, Garg A, Jack M, Mungai L, Oral EA, Patni N, Rother KI, von Schnurbein J, Sorkina E, Stanley T, Vigouroux C, Wabitsch M, Williams R, Yorifuji T.
J Clin Endocrinol Metab. 2016 Dec;101(12):4500-4511. doi: 10.1210/jc.2016-2466. Epub 2016 Oct 6.
Diagnosis and treatment of lipodystrophy: a step-by-step approach.
Araújo-Vilar D, Santini F.
J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27.
Lipodystrophy for the Diabetologist-What to Look For.
Patni N, Garg A.
Curr Diab Rep. 2022 Sep;22(9):461-470. doi: 10.1007/s11892-022-01485-w. Epub 2022 Jul 11.
Lipodystrophy syndromes.
Herranz P, de Lucas R, Pérez-España L, Mayor M.
Dermatol Clin. 2008 Oct;26(4):569-78, ix. doi: 10.1016/j.det.2008.05.004.
Autoimmunity in lipodystrophy syndromes.
Ceccarini G, Magno S, Gilio D, Pelosini C, Santini F.
Presse Med. 2021 Nov;50(3):104073. doi: 10.1016/j.lpm.2021.104073. Epub 2021 Sep 20.
Recent developments in lipodystrophy.
Melvin A, Stears A, Savage DB.
Curr Opin Lipidol. 2019 Aug;30(4):284-290. doi: 10.1097/MOL.0000000000000613.
Lipodystrophy: beyond generalization?
Freitas P, Carvalho D.
Panminerva Med. 2013 Sep;55(3):253-68.
Familial partial lipodystrophy syndromes.
Fernández-Pombo A, Sánchez-Iglesias S, Cobelo-Gómez S, Hermida-Ameijeiras Á, Araújo-Vilar D.
Presse Med. 2021 Nov;50(3):104071. doi: 10.1016/j.lpm.2021.104071. Epub 2021 Oct 2.
Partial lipodystrophy: Clinical presentation and treatment.
Mosbah H, Vatier C, Vigouroux C.
Ann Endocrinol (Paris). 2024 Jun;85(3):197-200. doi: 10.1016/j.ando.2024.05.015. Epub 2024 Jun 12.
